Lidocaine HCl Injection recall — Class III (D-0552-2026) · pharmaranks
Class IIIOngoing
Lidocaine HCl Injection recall
FDA recall D-0552-2026 · initiated May 18, 2026
Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why it was recalled
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Details
Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.